![Joanna Horobin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joanna Horobin
Director/Board Member at LIQUIDIA CORPORATION
Net worth: 2 472 $ as of 31/05/2024
Profile
Joanna C.
Horobin is currently serving as the Non-Executive Chairman at iOnctura SA since 2020.
She is also an Independent Director at Liquidia Technologies, Inc. since 2019, an Independent Director at Liquidia Corp.
since 2020, and an Independent Director at Vyant Bio, Inc. since 2021.
Additionally, she is a Member of the Royal College of General Practitioners.
Dr. Horobin has previously held positions as the President & Director at Syndax Pharmaceuticals, Inc. from 2006 to 2012, Director at The University of Manchester, Director at Nascent Pharmaceuticals, Inc., Independent Non-Executive Director at Nordic Nanovector ASA from 2016 to 2023, Independent Director at Kymera Therapeutics, Inc. from 2018 to 2024, Executive Vice President at CASI Pharmaceuticals, Inc., Chief Medical Officer & Senior Vice President at Idera Pharmaceuticals, Inc. from 2015 to 2019, Chief Operating Officer at CombinatoRx, Inc., Vice President-Oncology at Rhone-Poulenc Rorer, Inc., and Chief Medical Officer at Verastem, Inc. from 2012 to 2015.
Dr. Horobin holds a doctorate degree from The University of Manchester.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
VYANT BIO, INC.
0.20% | 30/06/2023 | 12,740 ( 0.20% ) | 2 472 $ | 31/12/2023 |
LIQUIDIA CORPORATION
-.--% | 26/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
07/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Joanna Horobin active positions
Companies | Position | Start |
---|---|---|
LIQUIDIA CORPORATION | Director/Board Member | 28/06/2020 |
VYANT BIO, INC. | Director/Board Member | 01/01/2021 |
Royal College of General Practitioners
![]() Royal College of General Practitioners Other Consumer ServicesConsumer Services The Royal College of General Practitioners is a professional membership body for family doctors in the UK and overseas. The non-profit company is based in London, UK and has subsidiaries in the United Kingdom. The British company is committed to improving patient care and clinical standards. The RCGP offers a fellowship program, which is the highest level of membership and exemplifies their motto "cum scientia caritas". The company also provides accreditation for high-quality resources and activities relevant to general practitioners. The Daffodil Standards is a free, evidence-based framework to help practices self-assess and consistently offer the best end of life and bereavement care. The RCGP represents the interests of established GPs and acts as a conduit for local matters to be raised at national meetings. | Corporate Officer/Principal | - |
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Director/Board Member | 11/09/2019 |
iOnctura SA
![]() iOnctura SA Miscellaneous Commercial ServicesCommercial Services iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland. | Chairman | 27/05/2020 |
Former positions of Joanna Horobin
Companies | Position | End |
---|---|---|
KYMERA THERAPEUTICS, INC. | Director/Board Member | 18/06/2024 |
THOR MEDICAL | Director/Board Member | 03/01/2023 |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Chief Tech/Sci/R&D Officer | 01/07/2019 |
VERASTEM, INC. | Chief Tech/Sci/R&D Officer | 01/07/2015 |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Joanna Horobin
The University of Manchester | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
SYNDAX PHARMACEUTICALS, INC. | Health Technology |
VERASTEM, INC. | Health Technology |
KYMERA THERAPEUTICS, INC. | Health Technology |
LIQUIDIA CORPORATION | Health Technology |
Private companies | 10 |
---|---|
Nascent Pharmaceuticals, Inc.
![]() Nascent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nascent Pharmaceuticals, Inc. manufactured pharmaceuticals and drugs. The company was founded by Charles P. R. de C. du Mée and Gene Barnett in 1999 and was headquartered in Durham, NC. | Health Technology |
Rhone-Poulenc Rorer, Inc.
![]() Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
CombinatoRx, Inc.
![]() CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Health Technology |
CASI Pharmaceuticals, Inc. /Old/
![]() CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Royal College of General Practitioners
![]() Royal College of General Practitioners Other Consumer ServicesConsumer Services The Royal College of General Practitioners is a professional membership body for family doctors in the UK and overseas. The non-profit company is based in London, UK and has subsidiaries in the United Kingdom. The British company is committed to improving patient care and clinical standards. The RCGP offers a fellowship program, which is the highest level of membership and exemplifies their motto "cum scientia caritas". The company also provides accreditation for high-quality resources and activities relevant to general practitioners. The Daffodil Standards is a free, evidence-based framework to help practices self-assess and consistently offer the best end of life and bereavement care. The RCGP represents the interests of established GPs and acts as a conduit for local matters to be raised at national meetings. | Consumer Services |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
Nordic Nanovector ASA
![]() Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
iOnctura SA
![]() iOnctura SA Miscellaneous Commercial ServicesCommercial Services iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland. | Commercial Services |
Vyant Bio, Inc. |
- Stock Market
- Insiders
- Joanna Horobin